CDC Narrows Its COVID-19 Vaccine Recommendations: What to Know
The Centers for Disease Control and Prevention has removed COVID-19 vaccines from immunization schedules for healthy children and pregnant women, according to Health Secretary Robert F. Kennedy Jr.
Kennedy
Here's what to know.
Child Recommendation Was Universal
The CDC in 2023
COVID-19 vaccines were recommended for children aged 6 months and up under the universal recommendation.
The recommendation advised doctors and parents that unvaccinated children under 5 should receive two doses of Moderna's vaccine or three doses of the Pfizer-BioNTech shot, unvaccinated children aged 5 to 11 should receive one dose of either shot, and unvaccinated children aged 12 to 18 should receive one dose of Moderna's vaccine, one dose of Pfizer's vaccine, or two doses of Novavax's shot.
Vaccinated children were recommended to receive at least one dose, depending on how many doses and which vaccines they'd received before.
Related Stories
5/27/2025
5/22/2025
According to the CDC, just 13 percent of youth and 14 percent of pregnant women have received one of the newest vaccines, which were
The CDC also
Recommendations Haven't Been Updated
Kennedy said in a video statement that 'as of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule.'
As of May 28, the CDC
The schedule was last updated on Nov. 21, 2024, according to the CDC's website.
The CDC
Both were last changed in June 2024, according to the site.
The CDC did not respond when asked when the schedules would be updated.
'As part of the Trump administration's commitment to common sense, the COVID-19 vaccine will be removed from the CDC's recommended immunization schedule,' a spokesperson for the Department of Health and Human Services, the CDC's parent agency, told The Epoch Times in an email.
Change Came Without Formal Advice
The CDC's vaccine advisers, the Advisory Committee on Immunization Practices, discussed COVID-19 vaccines during a meeting in April.
A subgroup of the panel that studied the matter
The advisers had been slated to vote on the topic during their next meeting, in June, according to the CDC.
The CDC is not bound by the committee's advice but often adopts it.
The panel in 2022
A dose of the COVID-19 vaccines available from 2023 to 2024 conferred an additional 52 percent protection for young children and 64 percent protection for those aged 5 to 17 against emergency department and urgent care encounters through August 2024, the CDC said in a
The American Academy of Pediatrics said the removal of the COVID-19 vaccines from the childhood schedule was concerning.
'By removing the recommendation, the decision could strip families of choice,' Dr. Sean O'Leary, chair of the academy's Committee on Infectious Diseases,
The American College of Obstetricians and Gynecologists (ACOG) also
'We are concerned about access implications and what this recommendation will mean for insurance coverage of the COVID-19 vaccine for those who do choose to get vaccinated during pregnancy,' ACOG said.
CDC's Involvement Unclear
It's not clear whether the CDC was involved in the decision to narrow the CDC's vaccine recommendations.
Kennedy's announcement was made alongside National Institutes of Health Director Dr. Jay Bhattacharya and Food and Drug Administration Commissioner Dr. Marty Makary.
The CDC currently has an acting director, a lawyer named Matthew Buzzelli, according to the health secretary. Buzzelli does not have a medical degree or public health experience, according to
President Donald Trump has named Susan Monarez, a CDC official with a doctorate in immunology and microbiology, as CDC director, but the Senate has not yet confirmed her.
Kennedy and the Department of Health and Human Services (HHS) have also not cited any studies in support of the change.
'As Commissioner Makary said, 'There's no evidence healthy kids need it today, and most countries stopped recommending it for children.' With the COVID-19 pandemic behind us, it is time to move forward,' a spokesperson for the department told The Epoch Times in an email. 'HHS and the CDC remain committed to gold standard science and to ensuring the health and well-being of all Americans—especially our nation's children—using common sense.'
COVID-19 cases and hospitalizations have fallen sharply since the Omicron variant sent them soaring in early 2022. The World Health Organization declared the pandemic over in the spring of 2023.
The removal came after FDA officials
The officials noted the low uptake of COVID-19 vaccines and said that they did not know, based on the available evidence, whether healthy people who previously had COVID-19 and were vaccinated would benefit from additional doses.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Texas Woman Dies From Brain-Eating Amoeba After Using RV Tap Water For Sinus Rinse
A Texas woman died from a rare and deadly brain infection after using unboiled tap water from an RV's water system for nasal irrigation while staying at a campground, according to the Centers for Disease Control and Prevention (CDC). The 71-year-old woman, who was healthy before the infection, used a nasal irrigation device with tap water from the RV's water system several times over four days. Within four days of her last use, she developed severe neurological symptoms, including fever, headache, and altered mental status, the CDC's Morbidity and Mortality Weekly Report stated. She developed seizures and died eight days after symptoms began. Laboratory testing confirmed Naegleria fowleri in her cerebrospinal fluid, indicating primary amebic meningoencephalitis (PAM), a disease with a fatality rate exceeding 97%. Naegleria fowleri, commonly known as the 'brain-eating amoeba,' is a free-living organism found in warm freshwater environments like lakes, rivers, and hot springs. Infections occur when contaminated water enters the nose, allowing the amoeba to travel to the brain. From 1962 to 2022, the U.S. reported 157 (primary amebic meningoencephalitis) PAM cases, with Texas accounting for 39. While most cases are linked to recreational water activities, nasal irrigation with contaminated water is a known risk. The CDC noted that the woman had no recent exposure to natural bodies of water, suggesting the RV's water system was the likely source of infection. The RV's water tank had been filled before the woman purchased it three months before her death, but the filling location is unknown. No samples from the campsite or RV water system tested positive for the amoeba, leaving the exact source of contamination unclear. The CDC emphasized that only distilled, sterile, or previously boiled water should be used for nasal rinsing, as tap water, even if safe for drinking, may contain organisms harmful when introduced into the nasal passages. To prevent PAM, the CDC recommends holding your nose or wearing a nose clip when diving into freshwater, keeping your head above water in hot springs, avoiding digging in shallow water, and using boiled or distilled water for nasal irrigation. The specific Texas campground where the infection occurred was not disclosed. This case underscores the critical need for public awareness about safe water use for nasal irrigation to prevent such rare but devastating infections.
New York Post
an hour ago
- New York Post
Menopause drug might prevent breast cancer and treat hot flashes, research finds
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, 'significantly reduced' breast tissue cell growth, which is a major indicator of cancer progression. Advertisement A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. Advertisement 'The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo,' Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. 5 New research from Northwestern University found that the drug Duavee 'significantly reduced' breast tissue cell growth, a major indicator of cancer progression. Marko Geber – Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. 'This would be expected, as the drug is FDA-approved to treat hot flashes.' Advertisement Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. 5 The women in the study were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Gorodenkoff – 5 Those who took the drug reported fewer hot flashes during the study. fizkes – The findings are preliminary and have not yet been published in a medical journal. Advertisement 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced 'high-risk lesions' — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. 'These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options,' the release stated. Study limitations The researchers said they are 'encouraged' by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. 'Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure,' Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. 5 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' Dr. Swati Kulkarni said. sarayutsridee – Advertisement 'While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk,' he told Fox News Digital. Kabraji also noted that the study focused on reducing levels of one specific protein, 'which does not always predict reduced recurrence of breast cancer.' 'This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer,' he noted. 5 According to Kulkarni,'larger studies with several years of follow-up are needed' to confirm that the drug prevents breast cancer. Science RF – Advertisement 'Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention.' Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. 'Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms,' she added.
CNN
2 hours ago
- CNN
Salmonella outbreak linked to eggs sickens dozens of people across 7 states
More than 70 people across seven states have been sickened due to a salmonella outbreak linked to eggs recalled by a California-based egg distributor, according to the US Centers for Disease Control and Prevention. On Friday, the August Egg Company recalled 1.7 million dozen brown cage-free and brown certified organic eggs, sold under multiple brand names, that have the 'potential to be contaminated,' according to a recall notice from the US Food and Drug Administration. Of the 79 people sickened, 21 people have been hospitalized and no deaths have been reported, the CDC said. The eggs were sold to restaurants and retailers in Arizona, California, Illinois, Indiana, Nebraska, New Mexico, Nevada, Washington and Wyoming, according to the CDC. They were distributed at retail locations including Walmart, Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less and Ralphs. Salmonella can 'cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems,' according to the FDA. Salmonella can also cause fever, diarrhea, nausea, vomiting and abdominal pain in healthy people who get infected. 'August Egg Company is not selling fresh shell eggs at this time. Our firm has voluntarily been diverting eggs to an egg-breaking plant for over 30 days, which pasteurizes the eggs and kills any potential foodborne pathogens,' the company said in a statement provided to the FDA. 'It is important to know that when our processing plant identified this concern, we immediately began diverting all eggs from the plant to an egg-breaking facility, which pasteurizes the eggs and kills any pathogens.' The company also said its internal food safety team is 'conducting its own stringent review' to identify future preventative measures. 'We are committed to addressing this matter fully and to implementing all necessary corrective actions to ensure this does not happen again,' the company said. The CDC recommends that anyone who has the recalled eggs in their home or business throw them out or return them to the store where they were purchased.
